Jiangsu Bioperfectus Technologies Co Ltd (688399) — Capital Reinvestment Ratio

Latest as of September 2025: 1.00x

Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Capital Reinvestment Ratio of 1.00x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥20.00 Million) in capital expenditures (CN¥20.05 Million). See 688399 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥20.00 Million
CNY

Capital Expenditures

CN¥20.05 Million
CNY

Data as of

Sep 2025
Most recent filing

Jiangsu Bioperfectus Technologies Co Ltd Capital Reinvestment Ratio (2016–2024)

This chart tracks Jiangsu Bioperfectus Technologies Co Ltd's Capital Reinvestment Ratio across 8 annual periods.

Annual Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

Year-by-year Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see Jiangsu Bioperfectus Technologies Co Ltd (688399) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.43x CN¥145.93 Million CN¥62.86 Million ▲ +141.3%
2022 0.18x CN¥1.96 Billion CN¥350.74 Million ▼ -42.1%
2021 0.31x CN¥985.52 Million CN¥303.62 Million ▲ +114.3%
2020 0.14x CN¥935.88 Million CN¥134.56 Million ▼ -85.5%
2019 0.99x CN¥106.72 Million CN¥105.77 Million ▼ -13.9%
2018 1.15x CN¥85.82 Million CN¥98.74 Million ▲ +141.8%
2017 0.48x CN¥61.59 Million CN¥29.31 Million ▼ -53.0%
2016 1.01x CN¥22.09 Million CN¥22.37 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow